Two of the FDA’s senior vaccine officials are leaving their positions as the agency mulls new rules and regulations over booster shots and Covid-19 vaccinations for children, according to Bloomberg and Endpoints News.
Departing the agency are Office of Vaccines Research and Review Director Marion Gruber, Ph.D. and Deputy Director Phillip Krause, M.D. Gruber plans to retire on Oct. 31, while Philips – deputy director for the FDA’s Center for Biologics Evaluation and Research, will be leaving in November.
U.S. health officials have been working to evaluate Covid vaccines and treatments at top speed, with shots from Moderna Inc., Johnson & Johnson and the partnership of Pfizer Inc. and BioNTech SE cleared in record time. Now the agency is charged with considering the administration’s booster program, which is set to roll out additional shots for most U.S. vaccinated adults Sept. 20. -Bloomberghttps://www.zerohedge.com/covid-19/two-senior-fda-officials-stepping-down-over-reported-disagreements-white-house-over
- Sweden’s Lund University researcher faces prosecution for study that showed most rapes are committed by immigrants
- Human beings aren’t clownfish
- Campus Crusade for Christ Goes All In On Critical Race Theory
- What the ever living? Report–Governor Kristi Noem is having an extramarital affair with adviser Corey Lewandowski
- Inside the January 6th Setup– Who is Ray Epps?
- Michigan High School Student Sues School for Suspending Him for Talking About Christian Beliefs in Private